Personal information

Emails & domains

Verified email domains

Websites & social links

Pr. Gaide group

Other IDs

Scopus Author ID: 57861071800
Scopus Author ID: 36052094500
Loop profile: 76021

Keywords

skin cancer, cancer microenvironment, Inflammation, Immunity, basal cell carcinoma, Melanoma, PPARs, Rho GTPases

Countries

France, Switzerland

Activities

Collapse all

Employment (3)

Centre Hospitalier Universitaire Vaudois: Lausanne, VD, CH

2018-12-01 to present | Chargée de recherche (Dermatologie)
Employment
Source: Self-asserted source
Christine Pich-Bavastro

Université de Lausanne Centre intégratif de génomique: Lausanne, VD, CH

2018-01-01 to 2018-05-31 | Chargé de recherche
Employment
Source: Self-asserted source
Christine Pich-Bavastro

Université de Lausanne Centre intégratif de génomique: Lausanne, VD, CH

2013-01-01 to 2017-12-31 | Première Assistante
Employment
Source: Self-asserted source
Christine Pich-Bavastro

Education and qualifications (5)

Swissethics: Lausanne, VD, CH

2019-09-02 to 2019-09-03 | Investigateur clinique
Qualification
Source: Self-asserted source
Christine Pich-Bavastro

CRPM: Lausanne, CH

2018-01 to 2018-02 | Project management basics
Education
Source: Self-asserted source
Christine Pich-Bavastro

RESAL: Lausanne, CH

2013 to 2013 | Module 1 “expérimentation animale”, “Association Suisse des Vétérinaires Cantonaux”
Education
Source: Self-asserted source
Christine Pich-Bavastro

Université Paul Sabatier: Toulouse, Midi-Pyrénées, FR

2008-10-01 to 2012-12-15 | PhD student (INSERM U1037)
Education
Source: Self-asserted source
Christine Pich-Bavastro

Ecole nationale vétérinaire de Toulouse: Toulouse, Midi-Pyrénées, FR

2012 to 2012 | Felasa C
Education
Source: Self-asserted source
Christine Pich-Bavastro

Funding (7)

101057622 — SEAWave — HORIZON-HLTH-2021-ENVHLTH-02

2022-07 to 2025-07 | Award
Horizon 2020 (Bern, CH)
Source: Self-asserted source
Christine Pich-Bavastro

ARP-T1 in Skin and Basal Cell Cancer

2017-04-01 to 2021-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.7082051
GRANT_NUMBER: 173102
Source: Self-asserted source
Christine Pich-Bavastro via DimensionsWizard

Activation of a tumor-friendly melanoma microenvironment by the nuclear receptor PPARgamma

2017-01 to 2017-06 | Grant
Swiss Foundation for Excellence and Talent in Biomedical Research (Basel, CH)
Source: Self-asserted source
Christine Pich-Bavastro

Control of skin responses to UV and skin carcinogenesis by the nuclear receptors PPARs

2016-10-01 to 2020-06-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.6804903
GRANT_NUMBER: 169232
Source: Self-asserted source
Christine Pich-Bavastro via DimensionsWizard

The nuclear receptor PPARγ, an activator of the pro-oncogenic pathway IL-1 in melanoma

2013 to 2015 | Grant
Fondation Pierre Mercier pour la Science (Pully, Vaud, CH)
Source: Self-asserted source
Christine Pich-Bavastro

Rho GTPases regulate immune ligands expression in melanoma

2011-10 to 2012-12 | Grant
Fondation Recherche Innovation Thérapeutique Cancérologie (Toulouse, FR)
Source: Self-asserted source
Christine Pich-Bavastro

RhoGTPases regulate immune ligands expression in melanoma

2008-10 to 2011-09 | Grant
Ministère de la Recherche et de l'Enseignement Supérieur (Paris, FR)
Source: Self-asserted source
Christine Pich-Bavastro

Works (50 of 135)

Items per page:
Page 1 of 3

Data from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6731683.v3
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Data from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.c.6731683
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S1 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032317.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S1 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032317
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S10 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032314.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S10 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032314
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S11 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032311.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S11 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032311
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S2 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032308
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S2 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032308.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032305
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032305.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S4 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032302
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S4 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032302.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032299
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032299.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S6 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032296
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S6 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032296.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032293.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032293
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S8 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032290
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S8 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032290.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S9 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032287
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S9 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032287.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S1 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032284
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S1 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032284.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S2 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032281
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S2 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032281.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032278.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S3 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032278
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S4 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032275.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S4 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032275
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032272.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S5 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032272
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S6 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032269
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S6 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032269.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032266.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Table S7 from Activin A-mediated polarization of cancer-associated fibroblasts and macrophages confers resistance to checkpoint immunotherapy in skin cancer

2024-09-16 | Preprint
DOI: 10.1158/1078-0432.27032266
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

Clinical Cancer Research
2023-09-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-0219
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Data from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.c.6731683.v2
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071436
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071436.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S10 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071433.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S10 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071433
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S11 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071427
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S11 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071427.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071424
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071424.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071421.v1
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref

Supplementary Figure S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

2023-09-01 | Preprint
DOI: 10.1158/1078-0432.24071421
Contributors: Christine Pich-Bavastro; Laura Yerly; Jeremy Di Domizio; Stéphanie Tissot-Renaud; Michel Gilliet; François Kuonen
Source: check_circle
Crossref
Items per page:
Page 1 of 3
How many people are using ORCID?